Skip to content
10-Q

Quarterly Report

LISATA THERAPEUTICS, INC. LSTA

0000320017-25-000060

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 7, 2025 8.76M sh
Shares Diluted Q2 2025 · Jun 30, 2025 8.61M sh
Shares Diluted Q2 2025 · Jun 30, 2025 8.6M sh
Shares Diluted Q2 2025 · Jun 30, 2024 8.31M sh
Shares Diluted Q2 2025 · Jun 30, 2024 8.3M sh
Capex Q2 2025 · Jun 30, 2025 $28K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$9.36M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$12.31M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $16.84M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $16.21M
Stockholders Equity Q2 2025 · Jun 30, 2025 $21.03M
Stockholders Equity Q2 2025 · Dec 31, 2024 $29.57M
Current Liabilities Q2 2025 · Jun 30, 2025 $4.31M
Current Liabilities Q2 2025 · Dec 31, 2024 $5.61M
Total Liabilities Q2 2025 · Jun 30, 2025 $4.39M
Total Liabilities Q2 2025 · Dec 31, 2024 $5.69M
Current Assets Q2 2025 · Jun 30, 2025 $24.89M
Current Assets Q2 2025 · Dec 31, 2024 $34.58M
Total Assets Q2 2025 · Jun 30, 2025 $25.16M
Total Assets Q2 2025 · Dec 31, 2024 $35M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.54
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.09
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.61
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.26
Eps Basic Q2 2025 · Jun 30, 2025 −$0.54
Eps Basic Q2 2025 · Jun 30, 2025 −$1.09
Eps Basic Q2 2025 · Jun 30, 2024 −$0.61
Eps Basic Q2 2025 · Jun 30, 2024 −$1.26
Sga Expense Q2 2025 · Jun 30, 2025 $2.69M
Sga Expense Q2 2025 · Jun 30, 2025 $5.93M
Sga Expense Q2 2025 · Jun 30, 2024 $2.92M
Sga Expense Q2 2025 · Jun 30, 2024 $6.28M
Net Income Q2 2025 · Jun 30, 2025 −$4.66M
Net Income Q2 2025 · Jun 30, 2025 −$9.38M
Net Income Q2 2025 · Jun 30, 2024 −$5.04M
Net Income Q2 2025 · Jun 30, 2024 −$10.45M
Operating Income Q2 2025 · Jun 30, 2025 −$4.87M
Operating Income Q2 2025 · Jun 30, 2025 −$10.72M
Operating Income Q2 2025 · Jun 30, 2024 −$5.52M
Operating Income Q2 2025 · Jun 30, 2024 −$12.12M
Revenue Q2 2025 · Jun 30, 2025 $70K
Revenue Q2 2025 · Jun 30, 2025 $70K
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $0